Concept information
Terme préférentiel
Aminolevulinic Acid
Type
-
mesh:Descriptor
Définition
- A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
Concept générique
Synonyme(s)
- 106-60-5 (Aminolevulinic Acid)
- 88755TAZ87
- Delta-Aminolevulinic Acid
- Pentanoic acid, 5-amino-4-oxo-
- V35KBM8JGR
Qualificatif(s) autorisé(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Action(s) pharmacologique(s)
Traductions
-
français
-
106-60-5 (Aminolevulinic Acid)
-
5-ALA (5-Amino-Levulinic Acid)
-
88755TAZ87
-
Acide 5-amino-lévulinique
-
Acide 5-aminolévulinique
-
Acide aminolévulinique
-
Acide delta-amino-lévulinique
-
Acide delta-aminolévulinique
-
Pentanoic acid, 5-amino-4-oxo-
-
V35KBM8JGR
URI
http://data.loterre.fr/ark:/67375/JVR-T78MJJCG-S
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}